DK260976A - Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroider - Google Patents

Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroider

Info

Publication number
DK260976A
DK260976A DK260976A DK260976A DK260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A
Authority
DK
Denmark
Prior art keywords
5alfa
delta9
ketosteroids
preparing
procedure
Prior art date
Application number
DK260976A
Other languages
English (en)
Other versions
DK137837C (da
DK137837B (da
Inventor
U Kerb
R Wiechert
O Engelfried
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK260976A publication Critical patent/DK260976A/da
Publication of DK137837B publication Critical patent/DK137837B/da
Application granted granted Critical
Publication of DK137837C publication Critical patent/DK137837C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK260976A 1975-06-11 1976-06-11 Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener DK137837C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2526373A DE2526373C2 (de) 1975-06-11 1975-06-11 Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden

Publications (3)

Publication Number Publication Date
DK260976A true DK260976A (da) 1976-12-12
DK137837B DK137837B (da) 1978-05-16
DK137837C DK137837C (da) 1978-10-23

Family

ID=5948981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260976A DK137837C (da) 1975-06-11 1976-06-11 Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener

Country Status (10)

Country Link
US (1) US4061661A (da)
JP (1) JPS51149260A (da)
CH (1) CH620452A5 (da)
DD (1) DD125699A5 (da)
DE (1) DE2526373C2 (da)
DK (1) DK137837C (da)
FR (1) FR2314197A1 (da)
GB (1) GB1554901A (da)
HU (1) HU174227B (da)
NL (1) NL7606137A (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4252719A (en) * 1978-08-17 1981-02-24 Research Corporation Steroid conversion method and products produced thereby
DE2929558C2 (de) * 1979-07-18 1982-03-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden
US4328162A (en) * 1980-09-05 1982-05-04 Eastman Kodak Company Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
EP2766380B1 (en) 2011-10-14 2019-04-24 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
US9512165B2 (en) 2013-04-17 2016-12-06 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PL2986624T3 (pl) 2013-04-17 2020-11-16 Sage Therapeutics, Inc. Neuroaktywne steroidy 19-NOR do stosowania w sposobach leczenia
DK3021852T3 (da) 2013-07-19 2021-03-15 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser deraf
CA3235088A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3206493B1 (en) 2014-10-16 2020-05-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SG10202009859YA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3250210B1 (en) 2015-01-26 2020-12-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
ES2935476T3 (es) 2015-02-20 2023-03-07 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US20180311258A1 (en) * 2015-04-10 2018-11-01 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス， インコーポレイテッド Ｃ７、ｃ１２、およびｃ１６置換神経刺激性ステロイドおよびそれらの使用方法
DK3481845T3 (da) 2016-07-11 2023-11-27 Sage Therapeutics Inc C17, c20 og c21 substituerede neuroaktive steroider og deres anvendelsesmetoder
EP3712161A1 (en) * 2019-03-19 2020-09-23 Bionice, S.L.U. Process for preparing high puritiy allopregnanolone and intermediates thereof
US11643434B2 (en) 2019-05-31 2023-05-09 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2681353A (en) * 1952-03-11 1954-06-15 Sterling Drug Inc Chlorination of keto-steroids
GB1380248A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy steroids and esters thereof

Also Published As

Publication number Publication date
FR2314197B1 (da) 1981-03-20
CH620452A5 (da) 1980-11-28
DE2526373A1 (de) 1976-12-30
DK137837C (da) 1978-10-23
FR2314197A1 (fr) 1977-01-07
DD125699A5 (da) 1977-05-11
DK137837B (da) 1978-05-16
GB1554901A (en) 1979-10-31
DE2526373C2 (de) 1983-11-10
US4061661A (en) 1977-12-06
HU174227B (hu) 1979-11-28
NL7606137A (nl) 1976-12-14
JPS51149260A (en) 1976-12-22
JPS6146480B2 (da) 1986-10-14

Similar Documents

Publication Publication Date Title
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK260976A (da) Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroider
DK143706C (da) Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser
DK484576A (da) Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser
DK87876A (da) Fremgangsmade til fremstilling af n-acyl-l-metionin
DK243176A (da) Fremgangsmade til fremstilling af polycliske forbindelser
DK164476A (da) Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK372576A (da) Fremgangsmade til fremstilling af polyaminforbindelser
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK362676A (da) Fremgangsmade til fremstilling af 1,4-dihydropyridiner
DK155598C (da) Fremgangsmaade til fremstilling af ethylchlorthioformiat
DK283476A (da) Fremgangsmade til fremstilling af beta-acylpyrroler
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK219776A (da) Fremgangsmade til fremstilling af 1,2-benzothiazin-oxadiazolforbindelse
DK280376A (da) Fremgangsmade til fremstilling af 1-acyl-1,2,3,4-tetrahydro-6-quinoliner
DK260876A (da) Fremgangsmade til fremstilling af delta9(11)-5alfa-d-homo-20-ketosteroider
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK192576A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporin-derivater
DK49276A (da) Fremgangsmade til fremstilling af biphenylylethere

Legal Events

Date Code Title Description
PBP Patent lapsed